Aerovate Therapeutics, Inc. (AVTE)
Market: NASD |
Currency: USD
Address: 930 Winter Street
Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
📈 Aerovate Therapeutics, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$3.00
-
Upside/Downside from Analyst Target:
9.09%
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
25-50%
-
Net Income Growth Range (1Y):
25-50%
-
Revenue Growth Range (1Y):
-
💰 Dividend History
Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
2025 |
- |
$0.028571 |
- |
2025-04-29 |
- |
Stock split |
$2.400000 |
- |
2025-04-25 |
- |
Dividend payout |
Total Amount for 2025: $2.428571 |
📅 Earnings & EPS History for Aerovate Therapeutics, Inc.
Date | Reported EPS |
---|
2026-03-25 (estimated upcoming) | - |
2025-11-10 (estimated upcoming) | - |
2025-11-09 (estimated upcoming) | - |
2025-08-11 (estimated upcoming) | - |
2025-08-10 (estimated upcoming) | - |
2025-05-12 | - |
2025-05-11 | - |
2025-03-27 | - |
2025-03-25 | -0.19 |
2025-03-23 | - |
2024-11-12 | -0.56 |
2024-08-12 | -0.86 |
2024-08-11 | -0.86 |
2024-05-13 | -0.83 |
2024-05-12 | -0.83 |
2024-03-25 | -0.74 |
2024-03-24 | -0.74 |
2023-11-13 | -0.71 |
2023-11-12 | -0.71 |
2023-08-14 | -0.76 |
2023-08-13 | -0.76 |
2023-05-15 | -0.67 |
2023-05-14 | -0.67 |
2023-03-29 | -0.61 |
2023-03-28 | -0.61 |
2022-11-14 | -0.56 |
2022-11-13 | -0.56 |
2022-08-15 | -0.49 |
2022-08-14 | -0.49 |
2022-05-16 | -0.45 |
2022-05-15 | -0.45 |
2022-03-30 | -0.35 |
2022-03-29 | -0.35 |
2021-11-15 | -0.26 |
2021-11-14 | -0.26 |
2021-08-16 | -23.8 |
2021-08-15 | -23.8 |
2021-06-30 | - |
2021-06-29 | - |
📰 Related News & Research
No related articles found for "aerovate therapeutics".